Carnegie Mellon University, Highmark Health and Allegheny Health Network in Pittsburgh announced the projects, which will all take place at Carnegie Mellon, on Feb. 12. The purpose of the projects is to provide research and technology to make healthcare more affordable, accessible and effective, according to a news release.
There will be a total of 16 projects, but seven major projects will receive $100,000 each, including:
∙ A method to increase efficiency and reduce side effects of nanotechnology-based anti-cancer drugs
∙ A microscopic radio-frequency identification device that reduces the number of counterfeit drugs entering the supply chain
∙ An improved detection technique for early stage melanoma lesions
∙ An automated methods to monitor and coach asthma patients using metered dose inhalers, giving patients more control over the medication
∙ A technique to detect the formation of biofilms on medical implants
∙ A robotic table to aid in orthopedic surgeries
∙ A cost-effective, sensitive and easy-to-use palpation tool to improve breast cancer self-screenings
This is the second round of projects to be funded. The first was announced in November 2013.
“Carnegie Mellon is at the center of the confluence of data analytics, machine learning, science and engineering. We are leveraging that expertise towards health care applications,” said Alan Russell, Ph.D., director of Carnegie Mellon’s Disruptive Health Technology Institute (DHTI) and Chief Innovation Officer for Allegheny Health Network.
